AVITA Medical (RCEL) Accumulated Depreciation & Amortization (2019 - 2025)
AVITA Medical (RCEL) has disclosed Accumulated Depreciation & Amortization for 6 consecutive years, with -$7.4 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Accumulated Depreciation & Amortization rose 19.59% year-over-year to -$7.4 million, compared with a TTM value of -$7.4 million through Dec 2025, up 19.59%, and an annual FY2025 reading of -$7.4 million, up 19.59% over the prior year.
- Accumulated Depreciation & Amortization was -$7.4 million for Q4 2025 at AVITA Medical, up from -$9.2 million in the prior quarter.
- Across five years, Accumulated Depreciation & Amortization topped out at -$355000.0 in Q3 2022 and bottomed at -$9.2 million in Q4 2024.
- Average Accumulated Depreciation & Amortization over 4 years is -$2.5 million, with a median of -$1.1 million recorded in 2022.
- The sharpest move saw Accumulated Depreciation & Amortization tumbled 771.98% in 2024, then grew 19.59% in 2025.
- Year by year, Accumulated Depreciation & Amortization stood at -$1.1 million in 2022, then increased by 1.68% to -$1.1 million in 2023, then crashed by 771.98% to -$9.2 million in 2024, then increased by 19.59% to -$7.4 million in 2025.
- Business Quant data shows Accumulated Depreciation & Amortization for RCEL at -$7.4 million in Q4 2025, -$9.2 million in Q4 2024, and -$1.1 million in Q4 2023.